A detailed history of Legal & General Group PLC transactions in Pep Gen Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 1,678 shares of PEPG stock, worth $6,913. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,678
Previous 1,678 -0.0%
Holding current value
$6,913
Previous $14,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$10.54 - $18.14 $8,695 - $14,965
825 Added 96.72%
1,678 $26,000
Q4 2023

Feb 15, 2024

SELL
$3.86 - $7.96 $1,100 - $2,268
-285 Reduced 25.04%
853 $5,000
Q2 2023

Aug 14, 2023

SELL
$8.94 - $16.39 $3,280 - $6,015
-367 Reduced 24.39%
1,138 $10,000
Q4 2022

Feb 14, 2023

BUY
$9.31 - $16.57 $7,475 - $13,305
803 Added 114.39%
1,505 $20,000
Q2 2022

Aug 22, 2022

BUY
$9.0 - $12.89 $6,318 - $9,048
702 New
702 $7,000

Others Institutions Holding PEPG

About PepGen Inc.


  • Ticker PEPG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,631,900
  • Market Cap $97.4M
  • Description
  • PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is a...
More about PEPG
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.